Skip to content

13F-HR filed by Lynx1 Capital Management LP

Lynx1 Capital Management LP filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-14, with 10 holding rows worth $114,610,000.

Accession
0001892688-22-000023
Filed
2022-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2021

A holdings report, 10 entries on the cover page, a total value of $114,610,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $114,610,000 with VALUE read as thousands by filing date, 13F file number 028-22151. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
MERUS N VN5749R100COM783,398$24,912,000thousands by filing date
TRAVERE THERAPEUTICS INC89422G107COM737,061$22,878,000thousands by filing date
ALPINE IMMUNE SCIENCES INC02083G100COM1,261,927$17,478,000thousands by filing date
BELLUS HEALTH INC NEW07987C204COM2,003,114$16,125,000thousands by filing date
IMMUNOGEN INC45253H101COMMON STOCK2,129,531$15,801,000thousands by filing date
PARDES BIOSCIENCES INC69945Q105COM401,593$6,574,000thousands by filing date
THESEUS PHARMACEUTICALS INC88369M101COM409,358$5,191,000thousands by filing date
CYMABAY THERAPEUTICS INC23257D103COM1,224,968$4,140,000thousands by filing date
PIERIS PHARMACEUTICALS INC720795103COM383,266$1,449,000thousands by filing date
OTONOMY INC68906L105COM30,000$62,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001892688-22-000023this filing2022-02-14acceptance time not in the bulk data set